| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $40.7M | +51.2% |
| SG&A Expense | $27.2M | +45.1% |
| Operating Income | -$67.9M | -48.7% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$65.6M | -44.1% |
| Income Tax | $0 | — |
| Net Income | -$66.7M | -41.8% |
| EPS (Basic) | -$2.09 | -13.6% |
| EPS (Diluted) | -$2.09 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.0M | -67.5% |
| Short-term Investments | $112.0M | — |
| Current Assets | $179.5M | -0.8% |
| Total Assets | $180.4M | -1.0% |
| Current Liabilities | $10.7M | +64.0% |
| Total Liabilities | $11.1M | +68.9% |
| Stockholders' Equity | $169.3M | -3.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.3M | -25.8% |
| Capital Expenditures | $54K | -83.8% |
| Investing Cash Flow | -$112.2M | -4708.0% |
| Financing Cash Flow | $51.1M | -38.4% |
| Free Cash Flow | -$57.3M | -25.0% |
| -13.6% |